StockData
Apimeds Pharmaceuticals US, Inc. logo

Apimeds Pharmaceuticals US, Inc. (APUS) income statement

APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$1.60−0.14 (-8.05%)

Close on Nov 20, 2026Market cap $2.41MP/E –Yield –

Apimeds Pharmaceuticals US, Inc. financial ratios

See a number that looks wrong?